utd_medknow
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :699
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Combined use of insoluble ß-glucan from the cell wall of Candida albicans and cyclophosphamide: Validation in S180 tumor-bearing mice
Yan Qi,Xin Hu,Jin Cui,Jing Chen,Qian Wu,Xiao Sun,Yan Shi
Biomedicine & Pharmacotherapy.2018;97()1366
[DOI]
2Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP10025–33 peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma
Xiaoli Chang,Chang-Qing Xia
Biochemical and Biophysical Research Communications.2015;468(1-2)46
[DOI]
3Biologic Response Modifiers: Relevance & Repercussions
Romesh Khardori,Nancy Misri Khardori
Infectious Disease Clinics of North America.2011;25(4)719
[DOI]
4Biologic Response Modifiers: Relevance & Repercussions
Sanyog Jain,Kaisar Raza,Ashish Kumar Agrawal,Ankur Vaidya
Infectious Disease Clinics of North America.2021;25(4)141
[DOI]
5Immunotherapy against cancer: A comprehensive review
Asfaw Geresu Minda,Feku Sultan Awel,Kassim Ahmed Seifudin,Mamo Kassa Gezahegne
Journal of Cancer Research and Experimental Oncology.2016;8(2)15
[DOI]
6Biologic response modifiers
Hoi Soo Yoon,Yong Sung Choi,Eun Hye Lee
Journal of the Korean Medical Association.2013;56(2)135
[DOI]
7Pharmacological Effects of Guava (Psidium guajava L.) Seed Polysaccharides: GSF3 Inhibits PC-3 Prostate Cancer Cell Growth through Immunotherapy In Vitro
Hsiao-Chien Lin,Jin-Yuarn Lin
International Journal of Molecular Sciences.2021;22(7)3631
[DOI]
8Tumor reductive therapies and antitumor immunity
Huiqin Guo,Kangla Tsung
Oncotarget.2017;8(33)55736
[DOI]
9The formulation for cancer prevention & therapy
Jerry T. Thornthwaite,Hare R. Shah,Pasupati Shah,William C. Peeples,Henry Respess
Advances in Biological Chemistry.2013;03(03)356
[DOI]
10Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors
Amir Sasan Mozaffari Nejad,Fatemeh Fotouhi,Parvaneh Mehrbod,Mohammad Yousef Alikhani
Saudi Journal of Biological Sciences.2021;28(10)5833
[DOI]
11An overview of cancer immunotherapeutic strategies
Braira Wahid,Amjad Ali,Shazia Rafique,Muhammad Waqar,Muhammad Wasim,Khansa Wahid,Muhammad Idrees
Immunotherapy.2018;10(11)999
[DOI]
12Alitretinoin in the treatment of cutaneous T-cell lymphoma
Till Kaemmerer,Pia-Charlotte Stadler,Leonie Helene Frommherz,Anne Guertler,Lars Einar French,Markus Reinholz
Cancer Medicine.2021;10(20)7071
[DOI]
13Effects of tumor vaccine expressing Granulocyte–Macrophage Colony Stimulating Factor and interleukin-18 fusion on cancer cells and its possible application for cancer immunotherapy
Sang Rok Lee,Young Kyu Park,Boo Ahn Shin,Hae-Ryoung Park
Cytokine.2017;89(20)143
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow